The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
Medtronic (NYSE:MDT) shares snapped seven straight days of losses as the stock closed 0.85% higher, at $88.98 on Thursday. ...
Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), ...
The FDA announced that Medtronic initiated a device recall and correction for embolization devices. The FDA has identified ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...
Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a product recall involving the company’s Pipeline Vantage 027 ...